| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
27,027 |
25,063 |
$6.00M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
33,066 |
31,379 |
$4.68M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
10,358 |
9,462 |
$2.80M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
14,877 |
13,377 |
$478K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
5,655 |
5,353 |
$402K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
4,235 |
1,894 |
$379K |
| G0378 |
Hospital observation service, per hour |
1,974 |
1,223 |
$367K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
14,414 |
13,587 |
$317K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
616 |
599 |
$314K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
60,734 |
49,893 |
$255K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
12,644 |
9,603 |
$199K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
429 |
406 |
$144K |
| 80053 |
Comprehensive metabolic panel |
42,783 |
35,003 |
$117K |
| 87276 |
|
15,127 |
14,355 |
$90K |
| 84484 |
|
6,861 |
5,624 |
$90K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
35,493 |
23,858 |
$87K |
| 71045 |
Radiologic examination, chest; single view |
8,410 |
7,740 |
$83K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
6,647 |
6,083 |
$72K |
| 71046 |
Radiologic examination, chest; 2 views |
4,821 |
4,556 |
$72K |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
3,834 |
3,253 |
$60K |
| 87275 |
|
15,126 |
14,355 |
$59K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
9,423 |
8,422 |
$57K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
2,226 |
2,032 |
$49K |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
683 |
602 |
$39K |
| 83690 |
|
8,977 |
8,224 |
$39K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
663 |
455 |
$37K |
| 97597 |
|
1,206 |
487 |
$32K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
12,549 |
10,835 |
$31K |
| 93458 |
|
59 |
56 |
$28K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
4,969 |
4,650 |
$27K |
| 77334 |
|
174 |
141 |
$26K |
| 77386 |
|
373 |
24 |
$25K |
| 80061 |
Lipid panel |
2,345 |
2,238 |
$24K |
| 77336 |
|
811 |
301 |
$24K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
484 |
233 |
$23K |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
292 |
275 |
$21K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,581 |
3,453 |
$19K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
3,902 |
3,384 |
$17K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
314 |
304 |
$16K |
| 36415 |
Collection of venous blood by venipuncture |
11,569 |
7,939 |
$15K |
| 70450 |
Computed tomography, head or brain; without contrast material |
835 |
772 |
$14K |
| 84703 |
|
2,527 |
2,309 |
$14K |
| 84443 |
Thyroid stimulating hormone (TSH) |
2,764 |
2,259 |
$13K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
251 |
239 |
$13K |
| 83735 |
|
3,293 |
2,697 |
$11K |
| 87081 |
|
3,228 |
3,117 |
$10K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
13,909 |
11,920 |
$10K |
| 81001 |
|
11,857 |
10,988 |
$10K |
| 96367 |
|
450 |
260 |
$9K |
| 45380 |
Colonoscopy, flexible; with biopsy, single or multiple |
14 |
12 |
$7K |
| 77300 |
|
95 |
77 |
$6K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
533 |
308 |
$6K |
| J1626 |
Injection, granisetron hydrochloride, 100 mcg |
158 |
49 |
$5K |
| 59025 |
Fetal non-stress test |
105 |
77 |
$4K |
| 82728 |
|
1,349 |
1,222 |
$4K |
| 86850 |
|
229 |
208 |
$4K |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
14 |
12 |
$4K |
| 81003 |
|
5,702 |
5,265 |
$4K |
| J1756 |
Injection, iron sucrose, 1 mg |
275 |
85 |
$4K |
| 84466 |
|
1,350 |
1,219 |
$3K |
| 84439 |
|
1,642 |
1,245 |
$3K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
1,161 |
1,047 |
$3K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
3,481 |
2,096 |
$3K |
| 86900 |
|
153 |
140 |
$3K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
43 |
40 |
$3K |
| 87807 |
|
549 |
537 |
$3K |
| 82077 |
|
755 |
670 |
$3K |
| 85027 |
|
963 |
816 |
$3K |
| J1453 |
Injection, fosaprepitant, 1 mg |
68 |
36 |
$2K |
| 97161 |
|
32 |
27 |
$2K |
| 74018 |
|
97 |
92 |
$2K |
| 85610 |
|
1,469 |
1,227 |
$2K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
55 |
55 |
$2K |
| 96417 |
|
67 |
26 |
$2K |
| 83540 |
|
1,382 |
1,246 |
$2K |
| 81025 |
|
716 |
650 |
$2K |
| 84100 |
|
924 |
776 |
$2K |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
14 |
12 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
165 |
153 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
852 |
802 |
$1K |
| 66984 |
Extracapsular cataract removal with insertion of intraocular lens prosthesis |
44 |
37 |
$1K |
| J1610 |
Injection, glucagon hydrochloride, per 1 mg |
27 |
25 |
$1K |
| 87040 |
|
137 |
123 |
$1K |
| 43450 |
|
14 |
13 |
$1K |
| 82140 |
|
159 |
138 |
$1K |
| 82607 |
|
419 |
389 |
$1K |
| 86901 |
|
153 |
140 |
$1K |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
50 |
28 |
$992.05 |
| 82550 |
|
434 |
331 |
$975.68 |
| 82805 |
|
63 |
54 |
$916.40 |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
15 |
12 |
$898.79 |
| 83605 |
|
255 |
215 |
$809.38 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
63 |
62 |
$793.88 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
63 |
62 |
$793.87 |
| 83525 |
|
108 |
106 |
$761.56 |
| 85730 |
|
255 |
220 |
$723.20 |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
451 |
409 |
$594.01 |
| 82746 |
|
169 |
156 |
$590.84 |
| 76775 |
|
13 |
12 |
$525.30 |
| J0690 |
Injection, cefazolin sodium, 500 mg |
210 |
167 |
$521.58 |
| 82533 |
|
372 |
208 |
$494.70 |
| 80076 |
|
175 |
159 |
$488.20 |
| 82553 |
|
298 |
218 |
$356.73 |
| 86140 |
|
334 |
314 |
$333.34 |
| 96523 |
|
32 |
27 |
$318.64 |
| 77417 |
|
91 |
39 |
$317.98 |
| 83880 |
|
49 |
42 |
$283.60 |
| 82330 |
|
55 |
33 |
$275.44 |
| 87205 |
|
46 |
38 |
$159.98 |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
15 |
12 |
$122.87 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
27 |
24 |
$121.86 |
| 86803 |
|
14 |
12 |
$106.25 |
| 85379 |
|
12 |
12 |
$97.59 |
| 85652 |
|
35 |
34 |
$90.89 |
| 87186 |
|
40 |
38 |
$84.80 |
| 83615 |
|
351 |
257 |
$82.68 |
| 87070 |
|
51 |
41 |
$59.10 |
| 88312 |
|
364 |
348 |
$39.20 |
| 82668 |
|
33 |
30 |
$38.67 |
| 86592 |
|
15 |
12 |
$29.60 |
| 82378 |
|
18 |
15 |
$26.02 |
| 87077 |
|
50 |
49 |
$25.48 |
| 84153 |
|
13 |
13 |
$25.24 |
| 82043 |
|
12 |
12 |
$11.91 |
| 82570 |
|
12 |
12 |
$10.65 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
7,211 |
6,651 |
$3.24 |
| A9270 |
Non-covered item or service |
2,781 |
1,835 |
$0.02 |
| J0744 |
Injection, ciprofloxacin for intravenous infusion, 200 mg |
152 |
137 |
$0.00 |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
451 |
393 |
$0.00 |
| C1760 |
Closure device, vascular (implantable/insertable) |
88 |
81 |
$0.00 |
| 85014 |
|
29 |
27 |
$0.00 |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
81 |
74 |
$0.00 |
| J1200 |
Injection, diphenhydramine hcl, up to 50 mg |
107 |
46 |
$0.00 |
| C9113 |
Injection, pantoprazole sodium, per vial |
85 |
52 |
$0.00 |
| J7510 |
Prednisolone oral, per 5 mg |
20 |
20 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
586 |
517 |
$0.00 |
| J3411 |
Injection, thiamine hcl, 100 mg |
154 |
141 |
$0.00 |
| 85018 |
|
29 |
27 |
$0.00 |
| C1769 |
Guide wire |
111 |
104 |
$0.00 |
| 83090 |
|
15 |
15 |
$0.00 |
| 83921 |
|
14 |
14 |
$0.00 |
| V2632 |
Posterior chamber intraocular lens |
64 |
50 |
$0.00 |